Abstract
As demonstrated in a number of chapters in this book,1 HIV prevention interventions can be highly cost-effective for society. In many instances, HIV prevention is actually cost-saving, meaning that the cost of the prevention intervention is more than offset by the savings in medical care costs. The net cost, therefore, is negative. (As discussed further later on, this is actually a very conservative interpretation of “cost saving” since it omits other important benefits of prevention, such as averting productivity losses.) Cost-saving programs represent unquestionably sound societal investments, because economic resources are conserved in the long run by implementing such programs. As a consequence, society should be willing to fund all cost-saving programs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Holtgrave DR, ed. Handbook of Economic Evaluation of HIV Prevention Programs. New York Plenum Press; 1998.
Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1982; 1: 61–80.
Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS and Behavior, in press.
Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York Oxford University Press; 1996.
Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York Oxford University Press; 1996.
Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716–721.
Gorsky RD, Haddix AC, Shaffer PA. Cost of an intervention. In Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York Oxford University Press; 1996.
Moreau W, Hager CJ. Determining the Unit Cost of Services: A Guide for Estimating the Cost of Services Funded by the Ryan White Care Act of 1990. Washington, DC: U.S. Department of Health and Human Services; 1993.
Schmid GP. Understanding the essentials of economic evaluation. J Acquired Immune Defic Syndr Hum Retrovirol 1995; 10(Suppl. 4): S6–S13.
Shaffer PA, Haddix AC. Time preference. In Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York Oxford University Press; 1996.
Pinkerton SD, Holtgrave DR, Leviton LC, Wagstaff DA, Cecil H, Abramson PR. Toward a standard sexual behavior data set for HIV prevention evaluation. Am J Health Behavior, in press.
Pinkerton SD, Abramson PR. The Bernoulli-process model of HIV transmission: Applications and implications. In Holtgrave DR, ed. Handbook of Economic Evaluation of HIV Prevention Programs. New York Plenum Press; 1998.
Kahn JG, Washington AE, Showstack JA, Berlin M, Phillips K. Updated Estimates of the Impact and Cost of HIV Prevention in Injection Drug Users. Final report prepared for the Centers for Disease Control and Prevention. San Francisco Institute for Health Policy Studies, University of California at San Francisco; 1992.
Weinstein MC, Graham JD, Siegel JE, Fineberg HV. Cost-effectiveness analysis of AIDS prevention programs: Concepts, complications, and illustrations. In Turner CF, Miller HG, Moses LE, eds. AIDS: Sexual Behavior and Intravenous Drug Use. Washington DC National Academy Press; 1989.
Pinkerton SD, Holtgrave DR, Leviton L, Wagstaff D, Abramson PR. Model-based evaluation of HIV prevention interventions. Evaluation Rev 1998; 22: 155–174.
Holtgrave DR, Leviton LC, Wagstaff D, Pinkerton SD. The cumulative probability of HIV infection: A summary risk measure for HIV prevention intervention studies. AIDS and Behavior 1997; 1: 169–172.
Hearst N, Hulley SB. Preventing the heterosexual spread of AIDS. JAMA 1988; 259: 2428–2432.
Pinkerton SD, Abramson PR. Evaluating the risks: A Bernoulli process model of HIV infection and risk reduction. Evaluation Rev 1993; 17: 504–528.
Reiss IL, Leik RK. Evaluating strategies to avoid AIDS: Number of partners vs. use of condoms. J Sex Res 1989; 26: 411–433.
Kahn JG. Are NEPs cost-effective in preventing HIV infection? In Lurie P, Reingold AL, eds. Public Health Impact of Needle Exchange Programs in the United States and Abroad. Berkeley: School of Public Health, University of California, 1993.
Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquired Immune Defic Synd Hum Retrovirol 1998; 18(Suppl. 1): S133–S138.
Holtgrave DR, Kelly JA. Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention. Am J Public Health 1996; 86: 1442–1445.
Kaplan EH. Modeling HIV infectivity: Must sex acts be counted? J Acquired Immune Defic Syndr 1990; 3: 55–61.
Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquired Immune Defic Syndr Hum Retrovirol 1997; 16: 54–62.
Guinan ME, Farnham PG, Holtgrave DR. Estimating the value of preventing a human immunodeficiency virus infection. Am J Preventive Med 1994; 10: 1–4.
Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel. JAMA 1996; 276: 146–154.
Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Antiretroviral therapy for HIV infection in 1996: Updated recommendations of the International AIDS Society—USA Panel. JAMA 1997; 277: 1962–1969.
Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York Oxford University Press; 1987.
Clemmer B, Haddix AC. Cost-benefit analysis. In Haddix AC, Teutsch SM, Shaffer PA, Duñet DO, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York Oxford University Press; 1996.
French MT, Mauskopf JA, Teague JL, Roland EJ. Estimating the dollar value of health outcomes from drugabuse interventions. Medical Care 1996; 9: 890–910.
Holtgrave DR, Quails NL. Threshold analysis and HIV prevention programs. Medical Decision Making 1995; 15: 311–317.
McKay NL, Phillips KM. An economic evaluation of mandatory premarital testing for HIV. Inquiry 1991; 28: 236–248.
Holtgrave DR, Kelly JA. Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention. Am J Public Health 1996; 86: 1442–1445.
Pinkerton SD, Holtgrave DR, DiFranceisco WJ, Stevenson LY, Kelly JA. Cost-effectiveness of a community-level HIV risk reduction intervention. Am J Public Health, in press.
Pinkerton SD, Holtgrave DR, Valdiserri RO. Cost-effectiveness of HIV prevention skills training for men who have sex with men. AIDS 1997; 11: 347–357.
Holtgrave DR, Kelly JA. The cost-effectiveness of an HIV/AIDS prevention intervention for gay men. AIDS and Behavior 1997; 1: 173–180.
Pinkerton SD, Holtgrave DR, Pinkerton HJ. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med 1997; 157: 1972–1980.
Pinkerton SD, Holtgrave DR, Bloom FR. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS 1998; 12: 1067–1078.
Pinkerton SD, Holtgrave DR, Bloom FR. Is postexposure prophylaxis for sexual or injection-associated exposure to HIV cost-effective? N Engl J Med 1997; 337: 500–501.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pinkerton, S.D., Holtgrave, D.R. (1998). Assessing the Cost-Effectiveness of HIV Prevention Interventions. In: Holtgrave, D.R. (eds) Handbook of Economic Evaluation of HIV Prevention Programs. AIDS Prevention and Mental Health. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1878-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1878-9_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1880-2
Online ISBN: 978-1-4899-1878-9
eBook Packages: Springer Book Archive